Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

Implantable pacemaker market slated to top $5.3B by 2023

The global market for implantable pacemakers is projected to see moderate, steady growth through 2023, resulting in a sum of more than $5.32 billion, according to a recent report.

Thumbnail

MaxQ AI’s ICH and stroke software to be available on Philips CT systems

MaxQ AI has announced that its AI-based intracranial hemorrhage (ICH) and stroke software will soon be integrated into Philips CT scanners.

Thumbnail

Income loss tied to elevated risk of CVD

A drop in income over six years was linked to a higher likelihood of CVD in a recent analysis of the ARIC study, suggesting financial stress might be a predictor of worse heart health in the U.S.

Thumbnail

VIDA Diagnostics, TeraRecon announce new partnership

VIDA Diagnostics, a Coralville, Iowa-based medical imaging company, has announced a new distribution deal with TeraRecon.

Thumbnail

2019 Group Practice Survey: The Exemplary 80

Radiology is evolving, consolidating and all the while innovating in this time of transition from volume to value across U.S. healthcare. A compressed field reflects the shape of the changed—and still changing—marketplace.

Thumbnail

Why the country’s largest public healthcare system is investing $224M to revamp its imaging strategy

NYC Health + Hospitals announced Wednesday, Oct. 9, it plans to invest nearly a quarter of $1 billion to upgrade its imaging capabilities, hoping to standardize care across the vast enterprise.

Thumbnail

AI could add $14T to global economy—but work still remains

As more businesses begin to implement state-of-the-art technologies, one industry expert is predicting AI will boost the global economy by $14 trillion by the year 2035.

Thumbnail

GE Healthcare, UK-based biotech company partner to tackle prostate cancer imaging

Imaging giant GE Healthcare announced this week that it’s teaming with biotech firm Theragnostics in a bid to improve prostate cancer treatment.